|

Actinomycin-D Clinical Trials

3 actively recruiting trials

Also known as: Dactinomycin

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Peking Union Medical College Hospital2
  • University of Birmingham1

Indications

  • Cancer3
  • Gestational Trophoblastic Neoplasia2
  • Rhabdomyosarcoma1

Other3 trials

FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Phase 1/2
Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7
Phase 2
Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.